APPLICATION OF PROMPT-QoL QUESTIONNAIRE IN PHARMACEUTICAL CARE

Phase 3

Completed

• Conditions: Chronic DiseaseDrug- related problemPoor medicine therapy- related quality of life; PROMPT- QoL; Pharmaceutical care; Drug- related problem; Medicine therapy- Communication

• Registration Number: TCTR20201208005
• Lead Sponsor: none

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-05-31
• Study Start: 2020-12-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 286

Inclusion Criteria

1) outpatients aged 18 or over
2) willing to participate in the study
3) having at least the following criteria
(a)receiving medicine treatment from more than one physician
(b)changing dosage regimens
(c) taking at least five medicines
(d) having abnormal laboratory caused by a medicine
(e) not complying to treatment regimen
(f) having an adverse drug reaction (ADR)

Exclusion Criteria

cognitive impairment or communicative problems

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Drug-related problems After doctor in first visit PROMPT-QoL, Drug-related problems classification,Outcome of drug-related problems assessment The follow-up visit (around 3 months) clinical outcome,Adherence to medication The follow-up visit (around 3 months) Medication Taking Behavior (MTB),Doctors acceptance of pharmacist recommendations for solutions to drug-related problems (DRP) After doctor in first visit Have drug change or dose adjustment or order laboratory test in subjects who have DRP,Communication about medicine therapy-related QoL between pharmacist and patient After doctor in first visit Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL), ,PROMPT-QOL score The follow-up visit (around 3 months) Patient-Reported Outcomes Measure of Pharmaceutical Therapy for Quality of Life (PROMPT-QoL),EuroQoL-5D score The follow-up visit (around 3 months) EQ-5D-5L (Thai-version)

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction The follow-up visit (around 3 months) Patient satisfaction questionnaire